Pharmaceutical Sciences and Research (PSR)
Not a member yet
124 research outputs found
Sort by
PERBANDINGAN EFIKASI BEBERAPA KOMBINASI ANTIRETROVIRAL PADA PASIEN HIV/AIDS DITINJAU DARI KENAIKAN JUMLAH CD4 RATA-RATA (ANALISIS DATA REKAM MEDIS DI RSK DHARMAIS JAKARTA TAHUN 2005 – 2006)
Get PDFDharmais Cancer Hospital is one of 237 hospital appointed by the government of Indonesia to give treatment, support and ARV therapy for HIV/AIDS patients. Ev-ery year, there is a significant increasing number of HIV/AIDS patients in DharmaisCancer Hospital, therefore successfully of therapy is needed to be carried out regularly for the optimum result to the patients. One of methods to evaluating therapy is by reviewing efficacy of ARV combinations toward escalation of immunity respond (es-calation of CD4). The ARV combinations give a good efficacy if increasing CD4 > 50 cell/mm3. The objective of this study was to know the efficacy of four ARV combina-tion (each type consists of two Nucleosides Reverse Transcriptase Inhibitor and one Non-Nucleosides Reverse Transcriptase Inhibitor) base on increasing CD4 mean HIV/AIDS patients after 6 – 12 months treatment in Dharmais Cancer Hospital from 2005 – 2006, and to compare the efficacy of four ARV combinations. The four ARVcombinations are combination I (Lamivudin + Zidovudin + Efavirenz), combina-tions II (Lamivudin + Zidovudin + Nevirapin), combination III (Lamivudin + Stavudin + Efavirenz), and combination IV (Lamivudin + Stavudin + Nevirapin).This study was analytical, cross-sectional design. Samples for this study were taken by total sampling using all data of HIV/AIDS patients in Dharmais Cancer Hospital from the year 2005 – 2006. The inclusion criteria were patients of fifteen years of age or more, baseline count CD4 < 200 cell/mm3, received ARV treatment for 6 – 12 months, received treatment of either one of the four ARV combination, and had dataof CD4 from laboratory result before and after the treatment. Data were taken from patients’ medical record and analyzed with ANOVA-test. The result of this study from 151 patients showed that all the four combinations gave good efficacy based on the increasing CD4 mean. There was a significant difference increasing CD4 mean to HIV/AIDS patients between those received ARV combination II and those received ARV combination III (p value = 0,032). And there was not a significant difference for the other combinations. This study was from the four ARV combinations gave two the best efficacy are combination II and combination III.Key words : Dharmais Cancer Hospital, HIV/AIDS patients, ARV combinations, efficacy ARV combination, increasing CD4
PURIFIKASI INHIBITOR ATPASE/RNA HELIKASE VIRUS JAPANESE ENCEPHALITIS DARI STREPTOMYCES CHARTREUSIS
Get PDFJapanese encephalitis virus (JEV) is a neuropathogenic virus commonly caused cen-tral nervous diseases such as meningitis and severe encephalitis. Although vaccine has been developed, no specific and effective drug is available so far. We previouslycarried out a screening of inhibitor of JEV RNA helicase, an enzyme that essential for virus replication, from Actinomycetes and found that Streptomyces chartreusis produce the inhibitor of JEV RNA helicase. In this study, an extracellular proteinwhich has inhibition activity on ATPase activity of JEV RNA helicase was purified from supernatant of Streptomyces chartreusis culture by ammonium sulfate pre-cipitation and size exclusion chromatography. SDS-PAGE analysis showed a singleband with aproximate molecular mass of 11,4 kDa, suggesting that the inhibitor was successfully purified into a single protein.Key words : Japanese encephaliti virus, RNA helikase Inhibitor, ATPase, Strepto-myces chartreusis
PEMBENTUKAN AKRILAMIDA DALAM MAKANAN DAN ANALISISNYA
Get PDFAcrylamide is a chemical substance which derived from acrylonitrile, is the material used in polyacrylamide production. Recent research has found acrylamide is contained in some food, especially food is rich in carbohydrate and treated in high temperature (more than 120°C). Due to its nature, acrylamide is classified as a hazardous material to be contained in human’s food. The International Agency for Research on Cancer (IARC) has classified acrylamide into group 2A (probably carcinogenic for humans). Many methods that used to analyse the acrylamide in some foods with sophisticated equipment, and in department of pharmacy FMIPA-UI there were also develop the method with simple extraction and conventional HPLC. Keywords : acrylamide, HPLC, carcinogenic
STUDI MUTASI TITIK A3243G DNA MITOKONDRIA PENYEBAB MATERNALLY INHERITED DIABETES AND DEAFNESS
Get PDFPoint mutation of mitochondrial DNA A3243G has been known as a cause of Mater-nally Inherited Diabetes and Deafness (MIDD). Potency of MIDD can be identified from patient phenotype of Non Insulin Dependent Diabetes Mellitus (NIDDM). The objective of this study is acquiring information about MIDD on patient of NIDDM type and obtaining the simple method to detect the point mutation of mtDNA A3243G.50 NIDDM patients were attained from RSCM Hospital, Jakarta. Information con-cerning family history with NIDDM and existences of deafness, medication, and other complication and manifestation were obtained through interview and ques-tioner. Point mutation of A3243G was determined with the method of PCR Allele’s Specific Amplification (PASA) Mismatch 2 bases and PCR-Restriction Length Poly-morphism (PCR-RFLP) with the HaeIIl restriction enzyme. Detectable Potency MIDDwas found by perceiving the patient phenotype and identifying the mutation of heteroplasmic A3243G utilizing the PASA method.Key words: MIDD, A3243G, mtDNA, PASA, PCR-RFLP